Expression of cellular retinoic acid binding protein 1 predicts peritoneal recurrence of gastric cancer.


Journal

International journal of oncology
ISSN: 1791-2423
Titre abrégé: Int J Oncol
Pays: Greece
ID NLM: 9306042

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 06 05 2021
accepted: 14 03 2022
entrez: 13 4 2022
pubmed: 14 4 2022
medline: 16 4 2022
Statut: ppublish

Résumé

To improve the outcome of gastric cancer, novel markers that predict postoperative prognosis are required. For this purpose, the function of cellular retinoic acid binding protein 1 (

Identifiants

pubmed: 35417033
doi: 10.3892/ijo.2022.5353
pii: 63
pmc: PMC9015192
doi:
pii:

Substances chimiques

RNA, Messenger 0
Receptors, Retinoic Acid 0
retinoic acid binding protein I, cellular 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Oncotarget. 2016 Aug 2;7(31):49322-49333
pubmed: 27384994
Am J Transl Res. 2018 Jan 15;10(1):292-303
pubmed: 29423014
Oncotarget. 2016 Mar 22;7(12):13667-79
pubmed: 26872374
World J Gastroenterol. 2016 Aug 14;22(30):6829-40
pubmed: 27570420
PLoS Biol. 2010 Jun 29;8(6):e1000412
pubmed: 20613859
Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96
pubmed: 24556840
Nat Rev Gastroenterol Hepatol. 2014 Nov;11(11):664-74
pubmed: 25134511
Clin Chim Acta. 2013 Sep 23;424:53-65
pubmed: 23669186
Ann Surg Oncol. 2016 Feb;23 Suppl 2:S214-21
pubmed: 25743330
Sci Rep. 2016 Mar 03;6:22396
pubmed: 26935534
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Oncogene. 2007 Sep 27;26(44):6456-68
pubmed: 17438526
Mol Cancer. 2015 Jul 05;14:129
pubmed: 26142905
Int J Oncol. 2017 Feb;50(2):381-386
pubmed: 28101581
Cancer Genet Cytogenet. 2010 Feb;197(1):16-24
pubmed: 20113832
J Exp Med. 2019 May 6;216(5):1016-1026
pubmed: 30975895
BMC Cancer. 2018 Jan 10;18(1):68
pubmed: 29321030
Trends Cell Biol. 2019 Mar;29(3):212-226
pubmed: 30594349
Cell Cycle. 2014;13(10):1530-9
pubmed: 24626200
Int J Cancer. 2003 May 10;104(6):735-44
pubmed: 12640681
Cancer Med. 2018 Oct;7(10):5194-5204
pubmed: 30259711
Surgery. 2015 Dec;158(6):1573-80
pubmed: 26120068
Int J Cancer. 2016 Feb 1;138(3):721-30
pubmed: 26270236
J Biol Chem. 1999 Aug 20;274(34):23695-8
pubmed: 10446126
World J Gastroenterol. 2014 Oct 14;20(38):13718-27
pubmed: 25320509
Sci Rep. 2017 Feb 06;7:42089
pubmed: 28165032
Ann Surg. 2018 Mar;267(3):495-503
pubmed: 28026832
Nat Rev Clin Oncol. 2013 Nov;10(11):643-55
pubmed: 24061039

Auteurs

Kazuki Sakata (K)

Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Showa‑ku, Nagoya 466‑8550, Japan.

Mitsuro Kanda (M)

Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Showa‑ku, Nagoya 466‑8550, Japan.

Dai Shimizu (D)

Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Showa‑ku, Nagoya 466‑8550, Japan.

Shunsuke Nakamura (S)

Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Showa‑ku, Nagoya 466‑8550, Japan.

Yoshikuni Inokawa (Y)

Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Showa‑ku, Nagoya 466‑8550, Japan.

Norifumi Hattori (N)

Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Showa‑ku, Nagoya 466‑8550, Japan.

Masamichi Hayashi (M)

Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Showa‑ku, Nagoya 466‑8550, Japan.

Chie Tanaka (C)

Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Showa‑ku, Nagoya 466‑8550, Japan.

Goro Nakayama (G)

Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Showa‑ku, Nagoya 466‑8550, Japan.

Yasuhiro Kodera (Y)

Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Showa‑ku, Nagoya 466‑8550, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH